Cargando…

Sex Differences in the Blood Concentration of Tacrolimus in Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients with CYP3A53/3

The purpose of this study was to describe the impact of sex and cytochrome P450 3A5 (CYP3A5) variant on the blood concentration of tacrolimus in patients with systemic lupus erythematosus or rheumatoid arthritis. The blood concentration of tacrolimus (ng/mL) divided by the daily dose of tacrolimus (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ito, Ayano, Okada, Yuko, Hashita, Tadahiro, Aomori, Tohru, Hiromura, Keiju, Nojima, Yoshihisa, Nakamura, Tomonori, Araki, Takuya, Yamamoto, Koujirou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438821/ https://www.ncbi.nlm.nih.gov/pubmed/28324194 http://dx.doi.org/10.1007/s10528-017-9795-8

Ejemplares similares

Effect of Ethanol in Paclitaxel Injections on the Ethanol Concentration in Exhaled Breath
por: Aomori, Tohru, et al.
Publicado: (2012)

Erratum in: Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib
por: Araki, Takuya, et al.
Publicado: (2013)

Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib
por: Araki, Takuya, et al.
Publicado: (2012)

Profiling of kidney involvement in systemic lupus erythematosus by deep learning using the National Database of Designated Incurable Diseases of Japan
por: Kimura, Tomonori, et al.
Publicado: (2023)

Risk of Falling and Hypnotic Drugs: Retrospective Study of Inpatients
por: Obayashi, Kyoko, et al.
Publicado: (2013)

Effect of CYP3A4*22, CYP3A5*3, and CYP3A Combined Genotypes on Cyclosporine, Everolimus, and Tacrolimus Pharmacokinetics in Renal Transplantation
por: Moes, D J A R, et al.
Publicado: (2014)

Novel approach for the detection of tubular cell migration into the interstitium during renal fibrosis in rats
por: Nakasatomi, Masao, et al.
Publicado: (2015)

Enhancement of HGF-induced tubulogenesis by endothelial cell-derived GDNF
por: Nakasatomi, Masao, et al.
Publicado: (2019)

Composite CYP3A (CYP3A4 and CYP3A5) phenotypes and influences on tacrolimus dose adjusted concentration in adult heart transplant recipients
por: Hernandez, Savine, et al.
Publicado: (2023)

Serum galectin-3 and galectin-3 binding protein levels in systemic lupus erythematosus and cutaneous lupus erythematosus
por: Kalinska-Bienias, Agnieszka, et al.
Publicado: (2020)

Identification of Urinary Activin A as a Novel Biomarker Reflecting the Severity of Acute Kidney Injury
por: Takahashi, Shunsuke, et al.
Publicado: (2018)

Urinary Activin A is a novel biomarker reflecting renal inflammation and tubular damage in ANCA-associated vasculitis
por: Takei, Yoshinori, et al.
Publicado: (2019)

Attenuation of renal fibrosis after unilateral ureteral obstruction in mice lacking the N-type calcium channel
por: Mishima, Keiichiro, et al.
Publicado: (2019)

Efficacy and Cytokine Modulating Effects of Tacrolimus in Systemic Lupus Erythematosus: A Review
por: Yoon, Kam Hon
Publicado: (2010)

Capability of Utilizing CYP3A5 Polymorphisms to Predict Therapeutic Dosage of Tacrolimus at Early Stage Post-Renal Transplantation
por: Niioka, Takenori, et al.
Publicado: (2015)

Importance of methodology in the evaluation of renal mononuclear phagocytes and analysis of a model of experimental nephritis with Shp1 conditional knockout mice
por: Watanabe, Mitsuharu, et al.
Publicado: (2020)

CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment
por: Chen, Lucy, et al.
Publicado: (2018)

Prediction of Tacrolimus Exposure by CYP3A5 Genotype and Exposure of Co-Administered Everolimus in Japanese Renal Transplant Recipients
por: Kagaya, Hideaki, et al.
Publicado: (2018)

Successful Treatment of Mucocutaneous Lupus Erythematosus in a Dog with Prednisolone, Mycophenolate Mofetil and Tacrolimus
por: Hyun, Jae-Eun, et al.
Publicado: (2021)

Effect of CYP3 A4, CYP3 A5 and ABCB1 gene polymorphisms on the clinical efficacy of tacrolimus in the treatment of nephrotic syndrome
por: Li, Min, et al.
Publicado: (2018)

The impact of CYP3A4 and CYP3A5 genetic variations on tacrolimus treatment of living‐donor Egyptian kidney transplanted patients
por: Wanas, Hanaa, et al.
Publicado: (2023)

Complement as a Biomarker for Systemic Lupus Erythematosus
por: Ayano, Masahiro, et al.
Publicado: (2023)

Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients
por: Qu, Lihui, et al.
Publicado: (2017)

Frequency of CYP3A5 Genetic Polymorphisms and Tacrolimus Pharmacokinetics in Pediatric Liver Transplantation
por: Buendía, Jefferson Antonio, et al.
Publicado: (2020)

Effects of CYP3A5 Genotypes on Thrombocytopenia in Liver Transplantation Patients Treated with Tacrolimus
por: Guo, Zhe, et al.
Publicado: (2023)

Follistatin, an Activin Antagonist, Ameliorates Renal Interstitial Fibrosis in a Rat Model of Unilateral Ureteral Obstruction
por: Maeshima, Akito, et al.
Publicado: (2014)

Pre-pregnancy serum complement C3 level is a predictor of preterm birth for pregnancies with systemic lupus erythematosus
por: Hiramatsu, Yuri, et al.
Publicado: (2021)

Tumid Lupus Erythematosus: An Intriguing Dermatopathological Connotation Treated Successfully with Topical Tacrolimus and Hydroxyxhloroquine Combination
por: Verma, Prashant, et al.
Publicado: (2014)

Clinical efficacy of tacrolimus in systemic lupus erythematosus with various manifestations: a real-world study
por: Bai, Wei, et al.
Publicado: (2022)

Impact of the CYP3A5, CYP3A4, COMT, IL-10 and POR Genetic Polymorphisms on Tacrolimus Metabolism in Chinese Renal Transplant Recipients
por: Li, Chuan-Jiang, et al.
Publicado: (2014)

The Analysis of Renal Infiltrating Cells in Acute Tubulointerstitial Nephritis Induced by Anti-PD-1 Antibodies: A Case Report and Review of the Literature
por: Tabei, Akifumi, et al.
Publicado: (2018)

The use of tacrolimus for recurrent lupus enteritis: a case report
por: Shirai, Tsuyoshi, et al.
Publicado: (2010)

Individualized treatment based on CYP3A5 single-nucleotide polymorphisms with tacrolimus in ulcerative colitis
por: Okabayashi, Shinji, et al.
Publicado: (2019)

Effect of CYP3A5 on the Once-Daily Tacrolimus Conversion in Stable Liver Transplant Patients
por: Kim, Jong Man, et al.
Publicado: (2020)

Correction: Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients
por: Qu, Lihui, et al.
Publicado: (2020)

CYP3A-status is associated with blood concentration and dose-requirement of tacrolimus in heart transplant recipients
por: Déri, Máté, et al.
Publicado: (2021)

Relationship between CYP3A5 Polymorphism and Tacrolimus Blood Concentration Changes in Allogeneic Hematopoietic Stem Cell Transplant Recipients during Continuous Infusion
por: Yoshikawa, Naoki, et al.
Publicado: (2021)

Upregulation of microRNA‐762 suppresses the expression of GIPC3 in systemic lupus erythematosus and neuropsychiatric systemic lupus erythematosus
por: Yang, Jijuan, et al.
Publicado: (2022)

Effect of belimumab on kidney-related outcomes in patients with lupus nephritis: post hoc subgroup analyses of the phase 3 BLISS-LN trial
por: Anders, Hans-Joachim, et al.
Publicado: (2023)

Expression of BAFF and BR3 in patients with systemic lupus erythematosus
por: Duan, J.H., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t5f5j4jhptcoci3a5es7k0lb1g